This Clinical Research in Pediatrics article discusses treatment options for pediatric patients with COVID-19 that are presenting signs and symptoms consistent with Kawasaki disease (KD).

In this Clinical Investigation London Journal article, Fatih Uckun M.D., Ph.D., discusses that because of the significance of the TGF-β pathway on the development of ARDS and T cell exhaustion, treatment with OT-101 may prevent the progression of evolving or mild ARDS and help facilitate the recovery of COVID-19 patients.

Find out what companies of all sizes are planning for in the coming 12 months and beyond—and how proactive, uncommon support from contract research organizations like Worldwide can help shape strategy, improve return on investment, and pave the way for smoother development journeys, from start to finish.  

In this International Biopharmaceutical Industry article, Scott Beasley and Rafal Ziecina M.D., Ph.D., discuss how non-invasive imaging is replacing liver biopsy as the gold standard for evaluation of fibrosis in non-alcoholic fatty liver disease (NAFLD).

Are you seeking a faster route to approval? Watch both sessions from our virtual event, highlighting alternatives to the traditional development path: There Can Only Be One: How to Achieve First to File Status and Zero Waste: The Quickest Path from Pilot to Pivotal.

In this Journal for Clinical Studies article, Michael Murphy, M.D., Ph.D., Melissa L. Vadnais VMD, Ph.D., and Andrew Kuhlman, MS, summarize the prevalence of wearable devices and their innovative applications in future clinical trials.